Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals

J Viral Hepat. 2010 Aug;17(8):588-97. doi: 10.1111/j.1365-2893.2009.01214.x. Epub 2009 Nov 2.

Abstract

Occult hepatitis B virus (O-HBV) infection is characterized by the presence of HBV DNA without detectable hepatitis B surface antigen (HBV DNA+/HBsAg-) in the serum. Although O-HBV is more prevalent during HBV/HIV co-infection, analysis of HBV mutations in co-infected patients is limited. In this preliminary study, HBV PreSurface (PreS) and surface (S) regions were amplified from 33 HIV-positive patient serum samples - 27 chronic HBV (C-HBV) and six O-HBV infections. HBV genotype was determined by phylogenetic analysis, while quasispecies diversity was quantified for the PreS, S and overlapping polymerase regions. C-HBV infections harboured genotypes A, D and G, compared to A, E, G and one mixed A/G infection for O-HBV. Interestingly, nonsynonymous-synonymous mutation values indicated positive immune selection in three regions for O-HBV vs one for C-HBV. Sequence analysis further identified new O-HBV mutations, in addition to several previously reported mutations within the HBsAg antigenic determinant. Several of these O-HBV mutations likely contribute to the lack of detectable HBsAg in O-HBV infection by interfering with detection in serologic assays, altering antigen secretion and/or decreasing replicative fitness.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Base Sequence
  • Cohort Studies
  • DNA, Viral / chemistry
  • DNA, Viral / genetics
  • Genetic Variation
  • Genotype
  • HIV / immunology*
  • HIV Infections / complications*
  • HIV Infections / immunology
  • HIV Infections / virology
  • Hepatitis B / complications*
  • Hepatitis B / immunology
  • Hepatitis B / virology
  • Hepatitis B Surface Antigens / genetics
  • Hepatitis B Surface Antigens / immunology*
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology*
  • Humans
  • Middle Aged
  • Molecular Sequence Data
  • Phylogeny*
  • Pilot Projects
  • Polymerase Chain Reaction
  • Prospective Studies
  • RNA-Directed DNA Polymerase / chemistry
  • RNA-Directed DNA Polymerase / genetics
  • Sequence Alignment
  • Sequence Analysis, DNA
  • Viral Structural Proteins / chemistry
  • Viral Structural Proteins / genetics
  • Young Adult

Substances

  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Viral Structural Proteins
  • RNA-Directed DNA Polymerase

Associated data

  • GENBANK/EU769235
  • GENBANK/EU769236
  • GENBANK/EU769237
  • GENBANK/EU769238
  • GENBANK/EU769239
  • GENBANK/EU769240
  • GENBANK/EU769241
  • GENBANK/EU769242
  • GENBANK/EU769243
  • GENBANK/EU769244
  • GENBANK/EU769245
  • GENBANK/EU769246
  • GENBANK/EU769247
  • GENBANK/EU769248
  • GENBANK/EU769249
  • GENBANK/EU769250
  • GENBANK/EU769251
  • GENBANK/EU769252
  • GENBANK/EU769253
  • GENBANK/EU769254
  • GENBANK/EU769255
  • GENBANK/EU769256
  • GENBANK/EU769257
  • GENBANK/EU769258
  • GENBANK/EU769259
  • GENBANK/EU769260
  • GENBANK/EU769261
  • GENBANK/EU769262
  • GENBANK/EU769263
  • GENBANK/EU769264
  • GENBANK/EU769265
  • GENBANK/EU769266
  • GENBANK/EU769267
  • GENBANK/EU769268
  • GENBANK/EU769269
  • GENBANK/EU769270
  • GENBANK/EU769271
  • GENBANK/EU769272
  • GENBANK/EU769273
  • GENBANK/EU769274
  • GENBANK/EU769275
  • GENBANK/EU769276
  • GENBANK/EU769277
  • GENBANK/EU769278
  • GENBANK/EU769279
  • GENBANK/EU769280
  • GENBANK/EU769281
  • GENBANK/EU769282
  • GENBANK/EU769283
  • GENBANK/EU769284
  • GENBANK/EU769285
  • GENBANK/EU769286
  • GENBANK/EU769287
  • GENBANK/EU769288
  • GENBANK/EU769289
  • GENBANK/EU769290
  • GENBANK/EU769291
  • GENBANK/EU769292